Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Genexine to Acquire EPD Bio, a Protein Degrader Startup, for $180 Million in Stock

publication date: Jul 10, 2024

South Korea’s Genexine will merge with EPD Biotherapeutics, a company developing an innovative targeted protein degradation (TPD) in exchange for 16% of Genexine’s stock, worth about $180 million. EPD has developed a bioPROTAC platform, known as EPDegTM, that is based on an mRNA-based bioPROTAC technology. The platform creates fusion-protein degraders delivered as mRNA-LNP that do not depend on tissue specific expression of E3 ligase. EPD believes the technology will overcome the limitations of existing small molecule-based PROTAC technology. More details....

Stock Symbol: (KOSDAQ: 095700)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here